Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Apogee Therapeutics CEO Michael Henderson Executes $1.67 Million Stock Sale Under Pre-Arranged Plan

Apogee Therapeutics CEO Michael Henderson Executes $1.67 Million Stock Sale Under Pre-Arranged Plan

Michael Thomas Henderson, Chief Executive Officer of Apogee Therapeutics, Inc. (NASDAQ: APGE), executed a sale of common stock totaling approximately $1,667,621 on June 10, 2026. The transaction involved the disposition of 19,000 shares, with per-share prices ranging from $82.21 to $86.89. These sales were conducted under a Rule 10b5-1 trading plan…

Star Equity Director Todd Fruhbeis Acquires Preferred Shares Amid Executive Compensation Adjustments

Star Equity Director Todd Fruhbeis Acquires Preferred Shares Amid Executive Compensation Adjustments

Todd Michael Fruhbeis, a director at Star Equity Holdings, Inc. (NASDAQ: STRR), executed a purchase of the company's Series A Preferred Stock on June 10, 2026. The transaction involved 300 shares acquired at a weighted average price of $9.81 per share. This acquisition brings his direct holdings to 5,411 shares. The insider activity coincides with …